Rawlins, M.D. and Culyer, A.J. (2004) National Institute for Clinical Excellence and its value judgments. BMJ. pp. 224-227. ISSN 1756-1833
Abstract
The National Institute for Clinical Excellence (NICE) offers health professionals in England and Wales advice on providing NHS patients with the highest attainable standards of care. NICE gives guidance on individual health technologies, the management of specific conditions, and the safety and efficacy of interventional diagnostic and therapeutic procedures. Guidance is based on the best available evidence. The evidence may not, however, be very good and is rarely complete. Those responsible for formulating the NICE’s advice therefore have to make judgments both about what is good and bad in the available science (scientific value judgments) and about what is good for society (social value judgments). In this article we focus on the scientific and social judgments forming the crux of the institute’s assessment of cost effectiveness. Scientific value judgments and those relating to clinical effectiveness are considered elsewhere.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2004 BMJ Publishing Group Ltd |
Keywords: | HEALTH-CARE,EUROQOL,EQUITY |
Dates: |
|
Institution: | The University of York |
Academic Units: | The University of York > Faculty of Social Sciences (York) > Economics and Related Studies (York) |
Depositing User: | Repository Officer |
Date Deposited: | 29 Sep 2004 |
Last Modified: | 02 Apr 2025 23:04 |
Published Version: | https://doi.org/10.1136/bmj.329.7459.224 |
Status: | Published |
Refereed: | Yes |
Identification Number: | 10.1136/bmj.329.7459.224 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:134 |